Phrs 564. Drug Delivery and Nanomedicine II PDF: Complete Guide

Phrs 564 is a graduate-level course covering advanced topics in drug delivery systems and nanomedicine. Students searching for a “phrs 564. drug delivery and nanomedicine ii pdf” are typically looking for course materials, lecture notes, or syllabi. This guide explains what the course covers, where to find legitimate materials, and how to approach the core subject matter.

Course Scope and Core Topics

Phrs 564 builds on foundational pharmaceutical sciences to focus on drug transport in the body and how nanoscale materials improve therapeutic outcomes.

Drug Transport Mechanisms

The course starts with how drug molecules move through biological barriers. Students study passive diffusion, carrier-mediated transport, and paracellular transport. A key concept is the relationship between a drug’s physicochemical properties (molecular weight, log P, pKa) and its ability to cross membranes. The course includes quantitative analysis using Fick’s laws of diffusion, with worked examples calculating flux across a membrane given concentration gradients and permeability coefficients.

Nanocarrier Design and Characterization

This section covers nanocarriers used in medicine: liposomes, polymeric nanoparticles, dendrimers, and solid lipid nanoparticles. Each carrier type has distinct properties regarding size, surface charge, drug loading capacity, and release kinetics. Characterization techniques include dynamic light scattering for size measurement, zeta potential analysis for surface charge, and encapsulation efficiency calculations. Students learn how particle size under 200 nm influences circulation time and tumor accumulation through the enhanced permeability and retention (EPR) effect.

Targeting Strategies

Passive targeting relies on the EPR effect for solid tumors. Active targeting uses ligands (antibodies, peptides, or small molecules) attached to the nanoparticle surface to bind specific receptors on target cells. The course discusses how ligand density, binding affinity, and receptor expression levels affect targeting efficiency. A common example is folate-conjugated nanoparticles targeting folate receptor-overexpressing cancer cells.

Where to Find Course Materials

Legitimate PDFs of Phrs 564 materials come from a few specific sources. Course syllabi and lecture slides are posted on university learning management systems that require login credentials. Publicly available resources include the National Center for Biotechnology Information NCBI for review articles on nanomedicine and the U.S. National Library of Medicine PubMed for research papers cited in the course. Some instructors make lecture notes available through university open courseware initiatives. Students should verify that any PDF matches their specific syllabus, since course content varies between institutions and semesters.

Key Concepts in Nanomedicine

Biocompatibility and Clearance

Nanoparticles must be biocompatible to avoid triggering immune responses. The course covers how particle surface chemistry affects opsonization (protein coating that marks particles for clearance) and subsequent uptake by the reticuloendothelial system. Polyethylene glycol (PEG) coating is a standard strategy to reduce opsonization and prolong circulation half-life. Students learn to calculate clearance rates and half-lives using pharmacokinetic models.

Drug Release Kinetics

Controlled release is a central goal of nanomedicine. The course compares diffusion-controlled, degradation-controlled, and stimuli-responsive release systems. pH-sensitive nanoparticles release drug in acidic tumor microenvironments; enzyme-responsive systems degrade in the presence of specific proteases. Mathematical models such as the Higuchi equation and the Korsmeyer-Peppas model fit release data and determine release mechanisms.

Regulatory and Manufacturing Considerations

Nanomedicine products face unique regulatory hurdles because their properties depend on size and surface characteristics that are difficult to control at scale. The course discusses FDA guidance on nanotechnology products and the importance of batch-to-batch consistency. Topics include sterilization methods that do not damage nanoparticles, long-term stability testing, and characterization of critical quality attributes.

Surface Modification Strategies

Beyond PEGylation, the course explores other surface modifications. Polysaccharide coatings like chitosan or hyaluronic acid provide mucoadhesive properties for oral or nasal delivery. Targeting ligands such as transferrin or RGD peptides are conjugated to nanoparticle surfaces to direct uptake by specific cell types. Students learn conjugation chemistry methods including carbodiimide coupling and maleimide-thiol reactions. The density of surface ligands matters: too few ligands gives poor targeting, too many can cause steric hindrance or trigger immune recognition.

Stimuli-Responsive Drug Delivery Systems

Internal stimuli exploit differences between healthy and diseased tissues. pH-responsive systems use polymers with ionizable groups that change conformation in acidic environments. Redox-responsive systems take advantage of higher glutathione concentrations inside cells compared to the bloodstream. Enzyme-responsive systems incorporate peptide sequences cleavable by matrix metalloproteinases overexpressed in certain cancers.

External stimuli allow spatiotemporal control of drug release. Thermosensitive systems use polymers like poly(N-isopropylacrylamide) that undergo a phase transition at body temperature. Magnetic nanoparticles generate heat when exposed to alternating magnetic fields, triggering drug release from thermosensitive coatings. Ultrasound-responsive nanocarriers release drug when acoustic cavitation disrupts their structure.

Analytical Methods

Dynamic light scattering measures hydrodynamic diameter and polydispersity index. A PDI below 0.2 indicates a monodisperse sample suitable for in vivo applications. Nanoparticle tracking analysis provides complementary measurements by tracking individual particle movement under Brownian motion. Transmission electron microscopy gives direct visualization of particle morphology but requires dry samples that may not reflect hydrated size.

Encapsulation efficiency is calculated as (mass of drug in nanoparticles / total mass of drug added) × 100%. Loading capacity is (mass of drug in nanoparticles / mass of nanoparticles) × 100%. Drug release studies use dialysis membrane methods or sample-and-separate techniques. Release profiles are fitted to mathematical models to determine release mechanisms.

In Vivo Considerations

Nanomedicines face complex biological barriers after administration. The course covers how nanocarriers behave in the bloodstream, including interactions with serum proteins that form a protein corona. This corona changes the effective size and surface properties of nanoparticles and can alter their targeting ability. The mononuclear phagocyte system in the liver and spleen clears most nanoparticles within hours. Strategies to evade uptake include particle size below 100 nm, neutral or slightly negative surface charge, and PEG coatings with molecular weight between 2000-5000 Da.

For cancer applications, nanoparticles must navigate the tumor microenvironment. Dense extracellular matrix, high interstitial fluid pressure, and poor vascular perfusion limit nanoparticle penetration. Smaller particles (20-50 nm) penetrate deeper into tumor tissue, while larger particles (100-200 nm) remain near blood vessels.

Applying the Material

Students apply Phrs 564 concepts to real-world problems through case studies. A typical assignment might ask students to design a nanocarrier for a poorly water-soluble anticancer drug. The solution involves selecting a suitable carrier (such as PLGA nanoparticles), calculating the required drug loading to achieve a therapeutic dose, and predicting release kinetics based on polymer degradation rate. Another common exercise is analyzing published research papers to critique experimental design and identify gaps in evidence for a specific nanomedicine platform.

Key Takeaways

• Phrs 564 covers drug transport, nanocarrier design, targeting strategies, and pharmacokinetics of nanomedicines.
• Course materials are available through university portals; public resources like NCBI and PubMed provide supporting literature.
• Core concepts include the EPR effect, opsonization, controlled release kinetics, and regulatory challenges for nanoscale products.
• Applying the material through case studies and research paper analysis builds practical skills for pharmaceutical research and development.